Phelan–McDermid Syndrome and SHANK3: Implications for Treatment

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurotherapeutics

• Publication date

  2015-04-17

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s13311-015-0352-zPMID 25894671PMCID PMC4489957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phelan-McDermid Syndrome

  2017cited by this paper
• A stepped wedge design for testing an effect of intranasal insulin on cognitive development of children with Phelan-McDermid syndrome: A comparison of different designs

  2017cited by this paper
• 22q11.2 deletion syndrome

  2015cited by this paper
• Recent advances of genomic testing in perinatal medicine.

  2015cited by this paper
• Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments

  2014cited by this paper
• Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

  2014cited by this paper
• Clinical and genomic evaluation of 201 patients with Phelan–McDermid syndrome

  2014influential reference
• Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring

  2014cited by this paper
• SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders

  2013cited by this paper
• Cerebellar and posterior fossa malformations in patients with autism‐associated chromosome 22q13 terminal deletion

  2013cited by this paper
• Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency

  2013influential reference
• Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay

  2013cited by this paper
• SHANK3 as an autism spectrum disorder-associated gene.

  2013cited by this paper
• SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients

  2013cited by this paper
• 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan–McDermid syndrome

  2013cited by this paper
• Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders

  2012cited by this paper
• High Proportion of 22q13 Deletions and SHANK3 Mutations in Chinese Patients with Intellectual Disability

  2012cited by this paper
• Autism spectrum disorders: a review of measures for clinical, health services and cost–effectiveness applications

  2012cited by this paper
• Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2

  2012cited by this paper
• Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms.

  2012cited by this paper
• Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills

  2012cited by this paper
• Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion.

  2012cited by this paper
• Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?

  2012cited by this paper
• Defects in translational regulation contributing to human cognitive and behavioral disease.

  2011cited by this paper
• Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

  2011cited by this paper
• The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)

  2011influential reference
• A Copy Number Variation Morbidity Map of Developmental Delay

  2011cited by this paper
• Protein Interactome Reveals Converging Molecular Pathways Among Autism Disorders

  2011influential reference
• Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.

  2011cited by this paper
• Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies.

  2011cited by this paper
• FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

  2011influential reference
• Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome

  2011cited by this paper
• Clinical utility gene card for: Deletion 22q13 syndrome

  2011cited by this paper
• Shank3 mutant mice display autistic-like behaviours and striatal dysfunction

  2011cited by this paper
• Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.

  2011cited by this paper
• Growth in Phelan–McDermid syndrome

  2011cited by this paper
• Defects in translational regulation contributing to human cognitive and behavioral disease.

  2011cited by this paper
• Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication

  2010influential reference
• Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH

  2010influential reference
• Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.

  2010cited by this paper
• Proline-rich synapse-associated protein-1 and 2 (ProSAP1/Shank2 and ProSAP2/Shank3)-scaffolding proteins are also present in postsynaptic specializations of the peripheral nervous system.

  2010cited by this paper
• mTOR signaling: at the crossroads of plasticity, memory and disease.

  2010cited by this paper
• Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

  2010cited by this paper
• Analysis of relative gene dosage and expression differences of the paralogs RABL2A and RABL2B by Pyrosequencing.

  2010cited by this paper
• The postsynaptic density proteins Homer and Shank form a polymeric network structure.

  2009cited by this paper
• NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats

  2009cited by this paper
• Monofluoride bridged, binuclear metallacycles of first row transition metals supported by third generation bis(1-pyrazolyl)methane ligands: unusual magnetic properties.

  2009cited by this paper
• Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection

  2009cited by this paper
• Effects of risperidone on glutamate receptor subtypes in developing rat brain.

  2009cited by this paper
• A synaptic trek to autism.

  2009cited by this paper
• Novel de novo SHANK3 mutation in autistic patients

  2009cited by this paper
• Scaffolding proteins at the postsynaptic density: shank as the architectural framework.

  2008cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review Deletion 22q13.3 syndrome

  2008cited by this paper
• Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

  2008cited by this paper
• Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood

  2008cited by this paper
• The role of recombinant insulin-like growth factor I in the treatment of the short child

  2007cited by this paper
• 22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay

  2007cited by this paper
• Cancer phenomics: RET and PTEN as illustrative models

  2007cited by this paper
• Effects of risperidone on dopamine receptor subtypes in developing rat brain.

  2007cited by this paper
• Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

  2007cited by this paper
• A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival

  2007cited by this paper
• Contribution of SHANK3 mutations to autism spectrum disorder.

  2007cited by this paper
• Direct interaction of post‐synaptic density‐95/Dlg/ZO‐1 domain‐containing synaptic molecule Shank3 with GluR1 α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptor

  2006cited by this paper
• A role for zinc in postsynaptic density asSAMbly and plasticity?

  2006cited by this paper
• An Architectural Framework That May Lie at the Core of the Postsynaptic Density

  2006cited by this paper
• PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.

  2005cited by this paper
• Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons

  2005cited by this paper
• Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities

  2005influential reference
• Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation

  2005cited by this paper
• C‐terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3

  2005cited by this paper
• Molecular and phenotypic characterization of ring chromosome 22

  2005influential reference
• Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.

  2004cited by this paper
• 22q13 deletion syndrome with central diabetes insipidus: a previously unreported association.

  2004cited by this paper
• Finishing the euchromatic sequence of the human genome

  2004cited by this paper
• Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum.

  2004cited by this paper
• Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3' untranslated region of Shank1 mRNA.

  2004cited by this paper
• Finishing the euchromatic sequence of the human genome

  2004cited by this paper
• Finishing the euchromatic sequence of the human genome

  2004cited by this paper
• Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations

  2003cited by this paper
• Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

  2003cited by this paper
• Reliability and Validity of an Assessment Instrument for Anxiety, Depression, and Mood Among Individuals with Mental Retardation

  2003influential reference
• FISH-mapping of a 100-kb terminal 22q13 deletion

  2002cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting.

  2002cited by this paper
• The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome.

  2002influential reference
• Synaptic Scaffolding Proteins in Rat Brain

  2001cited by this paper
• Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

  2001cited by this paper
• 22q13 deletion syndrome.

  2001cited by this paper
• Regulation of dendritic spine morphology and synaptic function by Shank and Homer.

  2001cited by this paper
• Synaptic Scaffolding Proteins in Rat Brain ANKYRIN REPEATS OF THE MULTIDOMAIN Shank PROTEIN FAMILY INTERACT WITH THE CYTOSKELETAL PROTEIN (cid:1) -FODRIN*

  2001cited by this paper
• Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype

  2000cited by this paper
• The Shank family of scaffold proteins.

  2000cited by this paper
• The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism

  2000cited by this paper
• The DNA sequence of human chromosome 21

  2000cited by this paper
• Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin.

  1999cited by this paper
• The DNA sequence of human chromosome 22

  1999cited by this paper
• Synapse structure: glutamate receptors connected by the shanks.

  1999cited by this paper
• Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

  1999cited by this paper
• The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.

  1999cited by this paper
• Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family.

  1999cited by this paper

• Disrupted cortex-wide dynamics impair motor planning in Shank3-mutant mice

  2026cites this paper
• Neurophysiological Profiles in a Family with Multiple SHANK3-Related Phelan–McDermid Syndrome Cases

  2026cites this paper
• Applying biologically anchored subtypes to advance precision medicine in autism spectrum disorder.

  2025cites this paper
• KBG syndrome complicated with chylothorax in a newborn: a case report and literature review

  2025cites this paper
• A Frank Assessment of SHANK: Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome

  2025cites this paper
• Extracellular Vesicles from Stem cells Rescue Cellular Phenotypes and Behavioral Deficits in SHANK3-Associated ASD Neuronal and Mouse Models

  2025cites this paper
• Age-dependent cortical overconnectivity in Shank3 mice is reversed by anesthesia

  2025cites this paper
• Phenotypic variation in neural sensory processing by deletion size, age, and sex in Phelan-McDermid syndrome

  2025cites this paper
• Quinoxyfen 1995-2019 is the story's end? Evaluation of its adverse effects on head size and nervous system genes involved in synaptic maturation.

  2025cites this paper
• Neurodevelopmental disorders and gut-brain interactions: exploring the therapeutic potential of pycnogenol through microbial-metabolic-neural networks

  2025cites this paper
• Clinical profiling and medical management of Israeli individuals with Phelan McDermid syndrome

  2025influential citation
• Orofacial Lymphedema in Phelan–McDermid Syndrome: A Case of Hemifacial Involvement and a Scoping Review

  2025cites this paper
• Genetic changes linked to two different syndromic forms of autism enhance reinforcement learning in early adolescent male but not female mice

  2025cites this paper
• Machine Learning for Prediction and Identification of Genetic Variants and Biomarkers in Autism Spectrum Disorder: A Systematic Review

  2025cites this paper
• Whole Exome Sequencing Uncovers the Genetic Complexity of Bicuspid Aortic Valve in Families with Early Onset Complications

  2024cites this paper
• Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis

  2024cites this paper
• Syndromic Association of Depigmentation With Congenital Hearing Loss: A Review of Three Children With Auditory Pigmentary Disorders.

  2024cites this paper
• Behavioral decline in Shank3Δex4–22 mice during early adulthood parallels cerebellar granule cell glutamatergic synaptic changes

  2024cites this paper
• Shank3 Overexpression Leads to Cardiac Dysfunction in Mice by Disrupting Calcium Homeostasis in Cardiomyocytes

  2024cites this paper
• Behavioral regression in shank3Δex4−22 mice during early adulthood corresponds to cerebellar granule cell glutamatergic synaptic changes

  2024cites this paper
• Whole-exome sequencing uncovers the genetic complexity of bicuspid aortic valve in families with early-onset complications.

  2024cites this paper
• Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.

  2024cites this paper
• New advances in the diagnosis and treatment of autism spectrum disorders

  2024cites this paper
• Behavioral and Psychiatric Disorders in Syndromic Autism

  2024cites this paper
• Understanding the role of AMPA receptors in autism: insights from circuit and synapse dysfunction

  2024cites this paper
• Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models.

  2023cites this paper
• Diversity and Classification of Genetic Variations in Autism Spectrum Disorder

  2023cites this paper
• Neurophysiological markers that links genes and behavior in humans: examples from rare genetic syndromes associated with autism spectrum disorders

  2023cites this paper
• Qualitative Insights into Key Angelman Syndrome Motor Related Concepts Reported by Caregivers—A Thematic Analysis of Semi-Structured Interviews

  2023cites this paper
• Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice.

  2023cites this paper
• Cromosoma 22 en anillo en paciente con trastorno del neurodesarrollo

  2023cites this paper
• Contemplating syndromic autism.

  2023cites this paper
• Adolescent sleep defects and dopaminergic hyperactivity in mice with a schizophrenia-linked Shank3 mutation.

  2023cites this paper
• Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics

  2023cites this paper
• Quantitative measures of motor development in Angelman syndrome

  2023cites this paper
• Activation of the CA2-ventral CA1 pathway reverses social discrimination dysfunction in Shank3B knockout mice

  2023cites this paper
• Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor

  2023cites this paper
• Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review

  2023influential citation
• The NO Answer for Autism Spectrum Disorder

  2023cites this paper
• Haploinsufficiency of Shank3 increases the orientation selectivity of V1 neurons

  2022cites this paper
• Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice

  2022cites this paper
• Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome: An Open-Label, Cross-Over, Preliminary Study

  2022cites this paper
• Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges

  2022cites this paper
• Clinical and Genetic Aspects of Phelan–McDermid Syndrome: An Interdisciplinary Approach to Management

  2022cites this paper
• Expression of SH3 and Multiple Ankyrin Repeat Domains Protein 3 in Mouse Retina

  2022cites this paper
• Activation of the CA2-vCA1 pathway reverses social discrimination dysfunction in Shank3B knockout mice

  2022cites this paper
• Effect of Early Swimming on the Behavior and Striatal Transcriptome of the Shank3 Knockout Rat Model of Autism

  2022cites this paper
• NDT_A_357338 681..694

  2022cites this paper
• Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism

  2022cites this paper
• Understanding Behavior in Phelan-McDermid Syndrome

  2022cites this paper
• Juvenile Shank3 KO Mice Adopt Distinct Hunting Strategies during Prey Capture Learning

  2022cites this paper
• SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system

  2022cites this paper
• Sleep and Phelan–McDermid Syndrome: Lessons from the International Registry and the scientific literature

  2022cites this paper
• Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells

  2022cites this paper
• Juvenile Shank3 KO mice adopt distinct hunting strategies during prey capture learning

  2022cites this paper
• The Shank3Venus/Venus knock in mouse enables isoform-specific functional studies of Shank3a

  2022cites this paper
• Burden of Rare Copy Number Variants in Microcephaly: A Brazilian Cohort of 185 Microcephalic Patients and Review of the Literature

  2022cites this paper
• A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy

  2021cites this paper
• SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice

  2021cites this paper
• Genetic determinants of autism spectrum disorders - a review

  2021cites this paper
• Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders

  2021cites this paper
• Relationships between SHANK3 and Autism Spectrum Disorder

  2021cites this paper
• The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia

  2021cites this paper
• Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice

  2021cites this paper
• The Neurological Manifestations of Phelan-McDermid Syndrome.

  2021cites this paper
• 40-Hz Auditory Steady-State Response (ASSR) as a Biomarker of Genetic Defects in the SHANK3 Gene: A Case Report of 15-Year-Old Girl with a Rare Partial SHANK3 Duplication

  2021cites this paper
• SHANK3 Genotype Mediates Speech and Language Phenotypes in a Nonclinical Population

  2021cites this paper
• Opportunities for ABA intervention in Phelan–McDermid syndrome

  2021cites this paper
• Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders

  2021influential citation
• A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome.

  2020cites this paper
• Deletion of c16orf45 in zebrafish results in a low fertilization rate and increased thigmotaxis.

  2020cites this paper
• Early Restoration of Shank3 Expression in Shank3 Knock-Out Mice Prevents Core ASD-Like Behavioral Phenotypes

  2020cites this paper
• Deficiency of SHANK3 isoforms impairs thermal hyperalgesia and dysregulates the expression of postsynaptic proteins in the spinal cord.

  2020cites this paper
• Sleep Duration in Mouse Models of Neurodevelopmental Disorders

  2020cites this paper
• A Case Report of Phelan-McDermid Syndrome: Successful Treatment with Growth Hormone Therapy

  2020cites this paper
• 40-Hz Auditory Steady State Response (ASSR) as a Biomarker of Abnormalities in SHANK3 Gene: a Case-Report of 15-years Old Girl with Rare Microduplication in 22q13.33

  2020cites this paper
• Prevalencia del síndrome de Phelan-McDermid en España

  2020cites this paper
• The specific role of zinc in autism spectrum disorders

  2020cites this paper
• Genetic Disorders and Dual Diagnosis: Building Clinical Management on Etiology and Neurocognition

  2020cites this paper
• Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach

  2020cites this paper
• Responsive Neurostimulation for Intractable Epilepsy in Phelan–McDermid Syndrome

  2020cites this paper
• A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case

  2019cites this paper
• Multiprotein Complexes

  2019cites this paper
• First-Tier Array CGH in Clinically Variable Entity Diagnosis: 22q13.3 Deletion Syndrome

  2019cites this paper
• A Systematic Literature Review of Behavioral Interventions for Phelan-McDermid Syndrome

  2018influential citation
• Shank3‐deficient rats exhibit degraded cortical responses to sound

  2018cites this paper
• Familial intellectual disability as a result of a derivative chromosome 22 originating from a balanced translocation (3;22) in a four generation family

  2018cites this paper
• Application of Human‐Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders

  2018cites this paper
• Phelan-McDermid syndrome, bipolar disorder and treatment with lithium

  2018cites this paper
• Effects of 5-HT1A Receptor Agonism on Repetitive Grooming and Learning Behavior in Shank3B Mice

  2018influential citation
• Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in Shank3-Overexpressing Mice

  2018cites this paper
• [Dichotomous classification of autism spectrum disorders: syndromal and non-syndromal forms].

  2018cites this paper
• Objective Measures of Electrophysiological Responses of Children with Idiopathic Autism Spectrum Disorder and Phelan-McDermid Syndrome to a Contrast-Reversing Checkerboard

  2017cites this paper
• Synaptic pathways related to Shank3 and its interaction partner ProSAPiP1

  2017cites this paper
• Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development

  2017cites this paper
• Expression of SHANK3 in the Temporal Neocortex of Patients with Intractable Temporal Epilepsy and Epilepsy Rat Models

  2017cites this paper
• Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements

  2017cites this paper
• University of Birmingham Prospective Study of Autism Phenomenology and the Behavioural Phenotype of Phelan-McDermid Syndrome:

  2017cites this paper
• Prospective study of autism phenomenology and the behavioural phenotype of Phelan–McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder

  2017cites this paper
• Modelling Autistic Neurons with Induced Pluripotent Stem Cells.

  2017cites this paper